ArticleMicrobial cell factories2026
Metabolic engineering for improved heterologous pinene production in the chloroplast of Phaeodactylum tricornutum.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Sustainable Lutein Production: Sources, Technologies, and Functional Applications.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe marine diatom Phaeodactylum tricornutum is a promising platform for the sustainable production of terpenoids. This is due to its robust photosynthetic growth and natural accumulation of terpenoids, mainly including photosynthetic pigments. P. tricornutum harbors the methyl-erythritol-phosphate (MEP) pathway in the chloroplast, a dedicated route used for the production of terpenoid-like photosynthetic pigments. Despite its natural predisposition for terpenoid production in the chloroplast, previously reported titers of heterologously produced terpenoids in P. tricornutum are relatively low.
resultsIn this study, we used a metabolic engineering strategy to enhance the production of the terpenoid pinene by increasing the production of their precursors. We episomically co-expressed either an isopentenyl diphosphate isomerase (IDI), a geranyl diphosphate synthase (GPPS), or both, along with a pinene synthase (PinS) in the chloroplast of P. tricornutum. We found that the combination of both IDI and GPPS leads to the hyperaccumulation of the monoterpenoid pinene, compared to the strain with only pinene synthase or IDI and GPPS expressed individually. Furthermore, the integration of all three genes in the genome resulted in a strain with a 92-fold higher pinene production, compared to the strain expressing only the pinene synthase. Lastly, we cultivated one of the high-performing transgenic strains at different light intensity regimes and found that the production of pinene increased at elevated light intensities.
conclusionIn this study, we performed metabolic engineering in the chloroplast of P. tricornutum by expressing heterologous IDI and GPPS together with a pinene synthase. We showed that this approach considerably boosted pinene production, especially in strains where the genes were randomly integrated in the genome. Moreover, we further increased pinene titers by modulating the light intensity during cultivation. Overall, we demonstrated the potential of combining metabolic engineering with optimized cultivation parameters, specifically light intensity, to enhance the production of monoterpenoids in the chloroplast of P. tricornutum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.